Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myeloma
Marietta Truger, Yoko Tamamushi, Max Köppel, Umair Munawar et al.
Journal
Haematologica
Topics
Multiple Myeloma Research and Treatments
article
Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myeloma
Marietta Truger, Yoko Tamamushi, Max Köppel, Umair Munawar, Johanna Lehmann, Christina Verbruggen, Silvia Nerreter, A. Rosenwald, Elena Hartmann, Seungbin Han, Cornelia Vogt, Johannes M. Waldschmidt, Fabian Schmitt, Hermann Einsele, Leo Rasche, Shilpa Kurian, Emma Besant, Ann-Sophie Hainold, Claudia Haferlach, Torsten Steinbrunn, Xiang Zhou, Martin K. Kortüm, Nina Rein, Leila Pfeiffer
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
University of Würzburg (DE), Munich Leukemia Laboratory (Germany) (DE), Dana-Farber Cancer Institute (US), Universitätsklinikum Würzburg (DE)
Funders
European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Deutsche Krebshilfe, Julius-Maximilians-Universität Würzburg